CU6 3.45% $5.60 clarity pharmaceuticals ltd

Ann: Complete response with Cu-67 SAR-bisPSMA, page-70

  1. 820 Posts.
    lightbulb Created with Sketch. 41
    If cu6's success exceed CEO's expectations, and the mkt cap correspondingly launches... Does going it alone come into play given attractive finance options... Or a favourable partnership whereby our other indications in development remain in cu6's hands ??? !!! Calculating valuation in this long term cash flow scenario makes present case valuation scenario peanuts.

    what are the chances?
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.